G. Dos Santos

发表

Rapid investigation of BA.4/BA.5 cases in France

A. Maisa, V. Enouf, L. Josset, 2022, Frontiers in Public Health.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Increasing prevalence and local transmission of non-B HIV-1 subtypes in the French Antilles and French Guiana between 1995 and 2018

R. Césaire, Mathieu Nacher, D. Descamps, 2020, Virus evolution.

Phylogeographic Analyses Reveal the Early Expansion and Frequent Bidirectional Cross-Border Transmissions of Non-pandemic HIV-1 Subtype B Strains in Hispaniola

R. Césaire, Mathieu Nacher, J. Boncy, 2019, Front. Microbiol..

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2013, The Journal of antimicrobial chemotherapy.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2010, The Journal of antimicrobial chemotherapy.

V. Calvez, C. Katlama, B. Masquelier, 2012, PloS one.

Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies.

R. Césaire, O. Béra, A. Cabié, 1999, Journal of acquired immune deficiency syndromes.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.

C. Delaugerre, S. Yerly, B. Masquelier, 2013, The Journal of antimicrobial chemotherapy.

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals

R. Tubiana, C. Katlama, O. Godin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

V. Calvez, Y. Yazdanpanah, J. Pawlotsky, 2022, Infectious diseases now.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients

V. Calvez, C. Charpentier, C. Delaugerre, 2009, Antimicrobial Agents and Chemotherapy.